Global Drug Repositioning Market Research Report 2025(Status and Outlook)
Description
Report Overview
Drug repositioning, also known as drug repurposing or reprofiling, refers to the process of identifying new therapeutic applications for existing drugs that were originally developed for different conditions. This approach leverages existing clinical, pharmacological, and safety data to accelerate development timelines, reduce costs, and mitigate risks associated with traditional drug discovery. The market for drug repositioning has gained significant traction due to the rising costs and high failure rates of novel drug development, coupled with increasing demand for faster, cost-effective treatments. Key drivers include advancements in computational biology, AI-driven drug discovery, and growing interest from pharmaceutical companies in maximizing the lifecycle of existing compounds. The market spans various therapeutic areas, including oncology, infectious diseases, and rare disorders, with significant potential in addressing unmet medical needs. Regulatory incentives, such as expedited approval pathways, further bolster its growth. However, challenges like intellectual property complexities and limited commercial incentives for off-label uses may hinder expansion. Overall, the drug repositioning market is poised for steady growth, driven by innovation, strategic collaborations, and the need for efficient therapeutic solutions.
The global Drug Repositioning market size was estimated at USD 30224.73 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 4.75% during the forecast period.
This report provides a deep insight into the global Drug Repositioning market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Drug Repositioning Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Drug Repositioning market in any manner.
Global Drug Repositioning Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Teva
Novartis
Mylan
Johnson and Johnson
Pfizer
Bausch Health
GSK
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Market Segmentation (by Type)
Generic Drugs
Clinical Trial Failed Drugs
Market Segmentation (by Application)
Cardiovascular Diseases
Mental Illness
Cancer
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Drug Repositioning Market
Overview of the regional outlook of the Drug Repositioning Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug Repositioning Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Drug Repositioning, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Drug repositioning, also known as drug repurposing or reprofiling, refers to the process of identifying new therapeutic applications for existing drugs that were originally developed for different conditions. This approach leverages existing clinical, pharmacological, and safety data to accelerate development timelines, reduce costs, and mitigate risks associated with traditional drug discovery. The market for drug repositioning has gained significant traction due to the rising costs and high failure rates of novel drug development, coupled with increasing demand for faster, cost-effective treatments. Key drivers include advancements in computational biology, AI-driven drug discovery, and growing interest from pharmaceutical companies in maximizing the lifecycle of existing compounds. The market spans various therapeutic areas, including oncology, infectious diseases, and rare disorders, with significant potential in addressing unmet medical needs. Regulatory incentives, such as expedited approval pathways, further bolster its growth. However, challenges like intellectual property complexities and limited commercial incentives for off-label uses may hinder expansion. Overall, the drug repositioning market is poised for steady growth, driven by innovation, strategic collaborations, and the need for efficient therapeutic solutions.
The global Drug Repositioning market size was estimated at USD 30224.73 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 4.75% during the forecast period.
This report provides a deep insight into the global Drug Repositioning market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Drug Repositioning Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Drug Repositioning market in any manner.
Global Drug Repositioning Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Teva
Novartis
Mylan
Johnson and Johnson
Pfizer
Bausch Health
GSK
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Market Segmentation (by Type)
Generic Drugs
Clinical Trial Failed Drugs
Market Segmentation (by Application)
Cardiovascular Diseases
Mental Illness
Cancer
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Drug Repositioning Market
Overview of the regional outlook of the Drug Repositioning Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug Repositioning Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Drug Repositioning, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
112 Pages
- 1 Research Methodology And Statistical Scope
- 1.1 Market Definition And Statistical Scope Of Drug Repositioning
- 1.2 Key Market Segments
- 1.2.1 Drug Repositioning Segment By Type
- 1.2.2 Drug Repositioning Segment By Application
- 1.3 Methodology & Sources Of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown And Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Drug Repositioning Market Overview
- 2.1 Global Market Overview
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size By Region
- 3 Drug Repositioning Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Drug Repositioning Product Life Cycle
- 3.3 Global Drug Repositioning Revenue Market Share By Company (2020-2025)
- 3.4 Drug Repositioning Market Share By Company Type (Tier 1, Tier 2, And Tier 3)
- 3.5 Drug Repositioning Company Headquarters, Area Served, Product Type
- 3.6 Drug Repositioning Market Competitive Situation And Trends
- 3.6.1 Drug Repositioning Market Concentration Rate
- 3.6.2 Global 5 And 10 Largest Drug Repositioning Players Market Share By Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 Drug Repositioning Value Chain Analysis
- 4.1 Drug Repositioning Value Chain Analysis
- 4.2 Midstream Market Analysis
- 4.3 Downstream Customer Analysis
- 5 The Development And Dynamics Of Drug Repositioning Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 Pest Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Drug Repositioning Market Porter's Five Forces Analysis
- 6 Drug Repositioning Market Segmentation By Type
- 6.1 Evaluation Matrix Of Segment Market Development Potential (Type)
- 6.2 Global Drug Repositioning Market Size Market Share By Type (2020-2025)
- 6.3 Global Drug Repositioning Market Size Growth Rate By Type (2021-2025)
- 7 Drug Repositioning Market Segmentation By Application
- 7.1 Evaluation Matrix Of Segment Market Development Potential (Application)
- 7.2 Global Drug Repositioning Market Size (M Usd) By Application (2020-2025)
- 7.3 Global Drug Repositioning Sales Growth Rate By Application (2020-2025)
- 8 Drug Repositioning Market Segmentation By Region
- 8.1 Global Drug Repositioning Market Size By Region
- 8.1.1 Global Drug Repositioning Market Size By Region
- 8.1.2 Global Drug Repositioning Market Size Market Share By Region
- 8.2 North America
- 8.2.1 North America Drug Repositioning Market Size By Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Drug Repositioning Market Size By Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Spain
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Drug Repositioning Market Size By Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Drug Repositioning Market Size By Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East And Africa
- 8.6.1 Middle East And Africa Drug Repositioning Market Size By Region
- 8.6.2 Saudi Arabia
- 8.6.3 Uae
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 Teva
- 9.1.1 Teva Basic Information
- 9.1.2 Teva Drug Repositioning Product Overview
- 9.1.3 Teva Drug Repositioning Product Market Performance
- 9.1.4 Teva Swot Analysis
- 9.1.5 Teva Business Overview
- 9.1.6 Teva Recent Developments
- 9.2 Novartis
- 9.2.1 Novartis Basic Information
- 9.2.2 Novartis Drug Repositioning Product Overview
- 9.2.3 Novartis Drug Repositioning Product Market Performance
- 9.2.4 Novartis Swot Analysis
- 9.2.5 Novartis Business Overview
- 9.2.6 Novartis Recent Developments
- 9.3 Mylan
- 9.3.1 Mylan Basic Information
- 9.3.2 Mylan Drug Repositioning Product Overview
- 9.3.3 Mylan Drug Repositioning Product Market Performance
- 9.3.4 Mylan Swot Analysis
- 9.3.5 Mylan Business Overview
- 9.3.6 Mylan Recent Developments
- 9.4 Johnson And Johnson
- 9.4.1 Johnson And Johnson Basic Information
- 9.4.2 Johnson And Johnson Drug Repositioning Product Overview
- 9.4.3 Johnson And Johnson Drug Repositioning Product Market Performance
- 9.4.4 Johnson And Johnson Business Overview
- 9.4.5 Johnson And Johnson Recent Developments
- 9.5 Pfizer
- 9.5.1 Pfizer Basic Information
- 9.5.2 Pfizer Drug Repositioning Product Overview
- 9.5.3 Pfizer Drug Repositioning Product Market Performance
- 9.5.4 Pfizer Business Overview
- 9.5.5 Pfizer Recent Developments
- 9.6 Bausch Health
- 9.6.1 Bausch Health Basic Information
- 9.6.2 Bausch Health Drug Repositioning Product Overview
- 9.6.3 Bausch Health Drug Repositioning Product Market Performance
- 9.6.4 Bausch Health Business Overview
- 9.6.5 Bausch Health Recent Developments
- 9.7 Gsk
- 9.7.1 Gsk Basic Information
- 9.7.2 Gsk Drug Repositioning Product Overview
- 9.7.3 Gsk Drug Repositioning Product Market Performance
- 9.7.4 Gsk Business Overview
- 9.7.5 Gsk Recent Developments
- 9.8 Chemrar Group
- 9.8.1 Chemrar Group Basic Information
- 9.8.2 Chemrar Group Drug Repositioning Product Overview
- 9.8.3 Chemrar Group Drug Repositioning Product Market Performance
- 9.8.4 Chemrar Group Business Overview
- 9.8.5 Chemrar Group Recent Developments
- 9.9 Glenmark
- 9.9.1 Glenmark Basic Information
- 9.9.2 Glenmark Drug Repositioning Product Overview
- 9.9.3 Glenmark Drug Repositioning Product Market Performance
- 9.9.4 Glenmark Business Overview
- 9.9.5 Glenmark Recent Developments
- 9.10 Fujifilm
- 9.10.1 Fujifilm Basic Information
- 9.10.2 Fujifilm Drug Repositioning Product Overview
- 9.10.3 Fujifilm Drug Repositioning Product Market Performance
- 9.10.4 Fujifilm Business Overview
- 9.10.5 Fujifilm Recent Developments
- 9.11 Dr. Reddy
- 9.11.1 Dr. Reddy Basic Information
- 9.11.2 Dr. Reddy Drug Repositioning Product Overview
- 9.11.3 Dr. Reddy Drug Repositioning Product Market Performance
- 9.11.4 Dr. Reddy Business Overview
- 9.11.5 Dr. Reddy Recent Developments
- 9.12 R-pharma
- 9.12.1 R-pharma Basic Information
- 9.12.2 R-pharma Drug Repositioning Product Overview
- 9.12.3 R-pharma Drug Repositioning Product Market Performance
- 9.12.4 R-pharma Business Overview
- 9.12.5 R-pharma Recent Developments
- 10 Drug Repositioning Market Forecast By Region
- 10.1 Global Drug Repositioning Market Size Forecast
- 10.2 Global Drug Repositioning Market Forecast By Region
- 10.2.1 North America Market Size Forecast By Country
- 10.2.2 Europe Drug Repositioning Market Size Forecast By Country
- 10.2.3 Asia Pacific Drug Repositioning Market Size Forecast By Region
- 10.2.4 South America Drug Repositioning Market Size Forecast By Country
- 10.2.5 Middle East And Africa Forecasted Sales Of Drug Repositioning By Country
- 11 Forecast Market By Type And By Application (2026-2033)
- 11.1 Global Drug Repositioning Market Forecast By Type (2026-2033)
- 11.2 Global Drug Repositioning Market Forecast By Application (2026-2033)
- 12 Conclusion And Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.